Form 8-K - Current report:
SEC Accession No. 0001615219-21-000013
Filing Date
2021-02-05
Accepted
2021-02-05 16:41:17
Documents
5
Period of Report
2021-02-05
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K salarius-8xksx3atmx4816x53.htm 8-K 30858
2 EX-1.1 salarius-ex11conformedsale.htm EX-1.1 267355
3 EX-5.1 salarius-ex51opinionatmx48.htm EX-5.1 6266
4 image_11.jpg GRAPHIC 137
5 image_21.jpg GRAPHIC 132
  Complete submission text file 0001615219-21-000013.txt   306262
Mailing Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021 346-772-0346
Salarius Pharmaceuticals, Inc. (Filer) CIK: 0001615219 (see all company filings)

EIN.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36812 | Film No.: 21596557
SIC: 2834 Pharmaceutical Preparations